References

  1. 2014 Copernicus Global Allergy Study
  2. IQVIA National Pharmacy OTC Allergy Sales MAT 18/02/2023.
  3. Penagos M, et al. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta‐analysis of randomized, double‐blind, placebo‐controlled, clinical trials. Allergy. 2008 Oct;63(10):1280-91.
  4. Graft D, et al. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray 1996; 98:724-731. Study funded by Schering-Plough Research Institute.
  5. Walls RS, at al. Optimising the management of allergic rhinitis: an Australian perspective. Medical journal of Australia. 2005 Jan;182(1):28-33. Study funded by GSK.
  6. Australian Society of Clinical Immunology and Allergy. Allergic rhinitis clinical update. Available at: https://www.allergy.org.au/hp/papers/allergic-rhinitis-clinical-update(accessed 10/12/2019).
  7. MAYO Clinic. Cold or allergy: which is it? Available at: https://www.mayoclinic.org/diseases-conditions/common-cold/expert-answers/common-cold/faq-20057857 (February 2020).
  8. Victoria State Government. Colds. Available at: https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/colds (accessed 9. May 2018).
  9. Australian Society of Clinical Immunology and Allergy. Allergen minimisation. Information for patients, consumers and carers. Available at: https://www.allergy.org.au/patients/allergy-treatment/allergen-minimisation (February 2020).
  10. Scadding GK, et al. BSACI guideline for the diagnosis and management of allergic and non‐allergic rhinitis (Revised Edition 2017; 2007). Clinical & Experimental Allergy. 2017 Jul;47(7):856-89.
  11. Walls RS, at al. Optimising the management of allergic rhinitis: an Australian perspective. Medical journal of Australia. 2005 Jan;182(1):28-33. Study funded by GSK.
  12. Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, Brignardello-Petersen R, Canonica GW, Casale T, Chavannes NH, de Sousa JC. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision. Journal of Allergy and Clinical Immunology. 2017 Oct 1;140(4):950-8.
  13. IQVIA National Pharmacy OTC Allergy Sales MAT 18/02/2023.
  14. Tan R, et al. Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon. Asthma research and practice. 2017 Dec;3(1):1-8.
  15. Blaiss MS. Quality of life in allergic rhinitis. Annals of Allergy, Asthma & Immunology. 1999 Nov 1;83(5):449-54.
  16. Fiftyfive5 project nose. October 2019. l12m allergy sufferers (N=448)
  17. Katelaris CH, et al. Nasal allergies in the Asian–Pacific population: results from the Allergies in Asia–Pacific Survey. American journal of rhinology & allergy. 2011 Sep;25(5_suppl):S3-15.